1 Curriculum Vitae Personal Information: First Name: Hamid Last Name: Badali Gender: Male Date of Birth: 15.April.1977 Place of Birth: Zanjan-Iran Nationality: Iranian Address: Department of Medical Mycology, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran. P.O. Box: 48175-1665 Sari-Iran. Fax: +98 11 3354 3087; Mobile: +98-912-841-3720 E-Mail: badalii@yahoo.com, badali.youngisham@gmail.com Present Statuas: Associate professor; PhD Departments of Medical Mycology/Invasive Fungi Research Center, School of Medicine, Mazandaran University of Medical Sciences Sari- Iran Educational Records: 1995 -1999: BSc: Cellular & molecular Microbiology, Zanjan University of medical Science. Iran (Date of graduated 19 Sept 1999) 16.04 of 20 2000-2003: MSc: Medical Mycology. Mazandaran University of Medical Sciences - Iran (Date of graduated 7 Dec 2002) 16.75 of 20 2006-2010: PhD: Medical and Molecular Mycology. Amsterdam University, Fungal Biodiversity Centre and in CBS institute –Netherlands (Date of graduated 25th June 2010) 2 Publications: Results: 109 109. Nasri E, Fakhim H, Vaezi A, Khalilzadeh S, Ahangarkani F, Laal Kargar M, Abtahian Z, Badali H*. Airway Colonization by Candida and Aspergillus species in Iranian Cystic Fibrosis Patients. Mycoses. 2019 Jan 25. doi: 10.1111/myc.12898. 108. Abastabar M, Hosseini T, Valadan R, Lagzian M, Haghani I, Aslani N, Badali H*, Nouripour-Sisakht S, Nazeri M, Gholami S, Vakili M, Bowyer P, Shokohi T, Hedayati MT. Novel Point Mutations in cyp51A and cyp51B Genes Associated with Itraconazole and Posaconazole Resistance in Aspergillus clavatus Isolates. Microb Drug Resist. 2019 Jan 18. doi: 10.1089/mdr.2018.0300. PubMed PMID: 30657433. 107. Arastehfar A, Fang W, Al-Hatmi AMS, Afsarian MH, Daneshnia F, Bakhtiari M, Sadati SK, Badali H, Khodavaysi S, Hagen F, Liao W, Pan W, Zomorodian K, Boekhout T. Unequivocal identification of an underestimated opportunistic yeast species, Cyberlindnera fabianii, and its close relatives using a dual-function PCR and literature review of published cases. Med Mycol. 2019 Jan 12. doi: 10.1093/mmy/myy148. PubMed PMID: 30649481. 106. Abastabar M, Haghani I, Ahangarkani F, Rezai MS, Taghizadeh Armaki M, Roodgari S, Kiakojuri K, Al-Hatmi AMS, Meis JF, Badali H*. Candida auris otomycosis in Iran and review of recent literature. Mycoses. 2018 Dec 26. doi: 10.1111/myc.12886. Review. PubMed PMID: 30585653. 105. Mohammadi R, Ansari Chaharsoghi M, Khorvash F, Kaleidari B, Sanei MH, Ahangarkani F, Abtahian Z, Meis JF, Badali H*. An unusual case of gastrointestinal basidiobolomycosis mimicking colon cancer; literature and review. J Mycol Med. 2018 Dec 12. pii: S1156- 5233(18)30263-4. doi: 10.1016/j.mycmed.2018.11.004. PubMed PMID: 30553627 104. Chaturvedi V, Bouchara JP, Hagen F, Alastruey-Izquierdo A, Badali H, Bocca AL, CanoLira JF, Cao C, Chaturvedi S, Chotirmall SH, van Diepeningen AD, Gangneux JP, Guinea J, de Hoog S, Ilkit M, Kano R, Liu W, Martinez-Rossi NM, de Souza Carvalho Melhem M, Ono MA, Ran Y, Ranque S, de Almeida Soares CM, Sugita T, Thomas PA, Vecchiarelli A, Wengenack NL, Woo PCY, Xu J, Zancope-Oliveira RM. Eighty Years of Mycopathologia: A Retrospective Analysis of Progress Made in Understanding Human and Animal Fungal Pathogens. Mycopathologia. 2018 Dec; 183 (6):859-877. doi: 10.1007/s11046-018-0306-1. PubMed PMID: 30506286. 103. Arastehfar A, Fang W, Pan W, Lackner M, Liao W, Badiee P, Zomorodian K, Badali H, Hagen F, Lass-Flörl C, Boekhout T. YEAST PANEL multiplex PCR for identification of clinically important yeast species: stepwise diagnostic strategy, useful for developing countries. 3 Diagn Microbiol Infect Dis. 2018 Sep 21. pii: S0732-8893(18)30381-X. doi: 10.1016/j.diagmicrobio.2018.09.007. PubMed PMID: 30377018. 102. Vaezi A, Fakhim H, Abtahian Z, Khodavaisy S, Geramishoar M, Alizadeh A, Meis JF, Badali H. Frequency and Geographic Distribution of CARD9 Mutations in Patients With Severe Fungal Infections. Front Microbiol. 2018 Oct 12;9:2434. doi: 10.3389/fmicb.2018.02434. eCollection 2018. Review. PubMed PMID: 30369919; PubMed Central PMCID: PMC6195074. 101. Pakshir K, Fakhim H, Vaezi A, Meis JF, Mahmoodi M, Zomorodian K, Javidnia J, Ansari S, Hagen F, Badali H*. Molecular epidemiology of environmental Cryptococcus species isolates based on amplified fragment length polymorphism. J Mycol Med. 2018 Oct 12. pii: S1156- 5233(18)30164-1. doi: 10.1016/j.mycmed.2018.09.005. PMID: 30322827. 100. Al-Hatmi AMS, Castro MA, de Hoog GS, Badali H, Alvarado VF, Verweij PE, Meis JF, Zago VV. Epidemiology of Aspergillus species causing keratitis in Mexico. Mycoses. 2018 Sep 26. doi: 10.1111/myc.12855. PMID: 30256460. 99. Diba K, Makhdoomi K, Nasri E, Vaezi A, Javidnia J, Gharabagh DJ, Jazani NH, Reza Chawshin A, Badiee P, Badali H, Fakhim H. Emerging Candida species isolated from renal transplant recipients: Species distribution and susceptibility profiles. Microb Pathog. 2018 Sep 18. pii: S0882-4010(18)30956-2. doi: 10.1016/j.micpath.2018.09.026. [Epub ahead of print] PubMed PMID: 30240817. 98. Abastabar M, Haghani I, Shokohi T, Hedayati MT, Aghili SR, Jedi A, Dadashi S, Shabanzadeh S, Hosseini T, Aslani N, Meis JF, Badali H*. Low in Vitro Antifungal Activity of Tavaborole Against Yeasts and Moulds from Onychomycosis. Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01632-18. doi: 10.1128/AAC.01632-18. 97. Arastehfar A, Fang W, Badali H, Vaezi A, Jiang W, Liao W, Pan W, Hagen F, Boekhout T. Low-Cost Tetraplex PCR for the Global Spreading Multi-Drug Resistant Fungus, Candida auris and Its Phylogenetic Relatives. Front Microbiol. 2018 May 29; 9:1119. doi: 10.3389/fmicb.2018.01119. eCollection 2018. PubMed PMID: 29896181; PubMed Central PMCID: PMC5987591. 96. Badali H, Rezaie S, Meis JF, Agha Kuchak Afshari S, Modiri M, Hagen F, Moazeni M, Mohammadi R, Khodavaisy S. Microsatellite genotyping of clinical Candida parapsilosis isolates. Curr Med Mycol. 2017 Dec; 3(4):15-20. doi: 10.29252/cmm.3.4.15. PubMed PMID: 29707674; PubMed Central PMCID: PMC5917096. 95. Motahari K, Badali H, Hashemi SM, Fakhim H, Mirzaei H, Vaezi A, Shokrzadeh M, Emami S. Discovery of benzylthio analogs of fluconazole as potent antifungal agents. Future Med Chem. 2018 Apr 23. doi: 10.4155/fmc-2017-0295. PubMed PMID: 29683339. 94. Zoran T, Sartori B, Sappl L, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, TajAldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Cascio GL, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, 4 Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Uzun O, Roudbary M, de la Fuente S, Houbraken J, Risslegger B, Lass-Flörl C, Lackner M. AzoleResistance in Aspergillus terreus and Related Species: An Emerging Problem or a Rare Phenomenon? Front Microbiol. 2018 Mar 28;9:516. doi: 10.3389/fmicb.2018.00516. eCollection 2018. PubMed PMID: 29643840; PMCID: PMC5882871. 93. Fakhim H, Vaezi A, Dannaoui E, Sharma C, Mousavi B, Chowdhary A, Meis JF, Badali H*. In vitro combination of voriconazole with micafungin against azole-resistant clinical isolates of Aspergillus fumigatus from different geographical regions. Diagn Microbiol Infect Dis. 2018 Mar 8. pii: S0732-8893(18)30081-6. doi: 10.1016/j.diagmicrobio.2018.03.003. PubMed PMID: 29622284. 92. Rezaei-Matehkolaei A, Khodavaisy S, Alshahni MM, Tamura T, Satoh K, Abastabar M, Shokoohi GR, Ahmadi B, Kord M, Taghipour S, Makimura K, Badali H*. In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators Against Dermatophyte Isolates. Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02423-17. doi: 10.1128/AAC.02423-17. PubMed PMID: 29530856. 91. Abastabar M, Al-Hatmi AMS, Moghaddam MV, de Hoog GS, Haghani I, Aghili SR, Shokohi T, Hedayati MT, Daie Ghazvini R, Kachuei R, Rezaei-Matehkolaei A, Makimura K, Meis JF, Badali H*. Potent Activity of Luliconazole, Lanoconazole and Eight Comparators against Molecularly Characterized Fusarium species. Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00009-18. doi: 10.1128/AAC.00009-18. PubMed PMID: 29530844. 90. Vaezi A, Fakhim H, Javidnia J, Khodavaisy S, Abtahian Z, Vojoodi M, Nourbakhsh F, Badali H*. Pesticide behavior in paddy fields and development of azole-resistant Aspergillus fumigatus: Should we be concerned? J Mycol Med. 2018 Feb 26. pii: S1156-5233(17)30282-2. doi: 10.1016/j.mycmed.2017.12.007. PMID: 29496370. 89. Fakhim H, Vaezi A, Dannaoui E, Chowdhary A, Nasiry D, Faeli L, Meis JF, Badali H. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Mycoses 2018. doi: 10.1111/myc.12754. PMID: 29460345. 88. Aslani N, Janbabaei G, Abastabar M, Meis JF, Babaeian M, Khodavaisy S, Boekhout T, Badali H*. Identification of uncommon oral yeasts from cancer patients by MALDI-TOF mass spectrometry. BMC Infect Dis. 2018 Jan 8; 18(1):24. doi: 10.1186/s12879-017-2916-5. PubMed PMID: 29310582. 87. Shokohi T, Aslani N, Ahangarkani F, Meyabadi MF, Hagen F, Meis JF, Boekhout T, Kolecka A, Badali H. Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients. Microb Pathog. 2017 Dec 29. pii: S0882-4010(17)31403-1. doi: 10.1016/j.micpath.2017.12.069. PubMed PMID: 29292174. 86: Mohammadi R, Mohammadi A, Ashtari F, Khorvash F, Hakamifard A, Vaezi A, Javidnia J, Meis JF, Badali H*. Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A Case and Review. Mycoses. 2018; 61: 261–265. doi: 10.1111/myc.12734. PMID: 29205524. 85. Badiee P, Badali H, Boekhout T, Diba K, Moghadam AG, Hossaini Nasab A, Jafarian H, Mohammadi R, Mirhendi H, Najafzadeh MJ, Shamsizadeh A, Soltani J. Antifungal susceptibility testing of Candida species isolated from the immunocompromised patients admitted to ten 5 university hospitals in Iran: comparison of colonizing and infecting isolates. BMC Infect Dis. 2017 Nov 21;17(1):727. doi: 10.1186/s12879-017-2825-7. PMID: 29157206 84: Agha Kuchak Afshari S, Rahimi H, Hashemi SJ, Daie Ghazvini R, Badali H, Aghaei Gharehbolagh S, Rezaie S. Evaluation of PCR-reverse line blot hybridization assay for simultaneous identification of medically important saprophytic fungi. J Mycol Med. 2017 Oct 31. pii: S1156-5233(17)30244-5. doi: 10.1016/j.mycmed.2017.09.002. PMID: 29100947. 83. Falahatinejad M, Vaezi A, Fakhim H, Abastabar M, Shokohi T, Zahedi N, Ansari S, Meis JF, Badali H*. Use of CSP typing for genotyping of azole-resistant and -susceptible Aspergillus fumigatus isolates in Iran. Mycoses. 2017 Oct 24. doi: 10.1111/myc.12717. [Epub ahead of print] PubMed PMID: 29064130. 82. Vaezi A, Fakhim H, Arastehfar A, Shokohi T, Hedayati MT, Khodavaisy S, RezaeiMatehkolaei A, Badiee P, Hagen F, Lass-Flörl C, Dannaoui E, Meis JF, Badali H*. In vitro antifungal activity of amphotericin B and eleven comparators against Aspergillus terreus species complex. Mycoses. 2017 Oct 24. doi: 10.1111/myc.12716. [Epub ahead of print] PubMed PMID: 29064123. 81. Hagen F, Lumbsch HT, Arsic Arsenijevic V, Badali H, Bertout S, Billmyre RB, Bragulat MR, Cabañes FJ, Carbia M, Chakrabarti A, Chaturvedi S, Chaturvedi V, Chen M, Chowdhary A, Colom MF, Cornely OA, Crous PW, Cuétara MS, Diaz MR, Espinel-Ingroff A, Fakhim H, Falk R, Fang W, Herkert PF, Ferrer Rodríguez C, Fraser JA, Gené J, Guarro J, Idnurm A, IllnaitZaragozi MT, Khan Z, Khayhan K, Kolecka A, Kurtzman CP, Lagrou K, Liao W, Linares C, Meis JF, Nielsen K, Nyazika TK, Pan W, Pekmezovic M, Polacheck I, Posteraro B, de Queiroz Telles F Filho, Romeo O, Sánchez M, Sampaio A, Sanguinetti M, Sriburee P, Sugita T, TajAldeen SJ, Takashima M, Taylor JW, Theelen B, Tomazin R, Verweij PE, Wahyuningsih R, Wang P, Boekhout T. Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus. mSphere. 2017 Aug 30;2(4). pii: e00238-17. doi: 10.1128/mSphere.00238-17. eCollection 2017 Jul-Aug. PubMed PMID: 28875175; PubMed Central PMCID: PMC5577652. 80. Shokoohi GR, Badali H, Mirhendi H, Ansari S, Rezaei-Matehkolaei A, Ahmadi B, Vaezi A, Alshahni MM, Makimura K. In Vitro Activity of Luliconazole, Lanoconazole, and Efinaconazole Compared with Five Antifungal Drugs Against Melanized Fungi and Relatives. Antimicrob Agents Chemother. 2017 Aug 28. pii: AAC.00635-17. doi: 10.1128/AAC.00635-17. PMID: 28848012. 79. Fakhim H, Chowdhary A, Prakash A, Vaezi A, Dannaoui E, Meis JF, Badali H*. In vitro interactions of echinocandins with triazoles against multidrug-resistant Candida auris. Antimicrob Agents Chemother. 2017 Aug 28. pii: AAC.01056-17. doi: 10.1128/AAC.01056-17. [Epub ahead of print] PubMed PMID: 28848002. 78. Zahedi N, Abedian Kenari S, Mohseni S, Aslani N, Ansari S, Badali H*. Is human Dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis? Curr Med Mycol. 2016 Sep; 2(3):15-19. doi: 10.18869/acadpub.cmm.2.3.15. PMID: 28681024; PubMed Central PMCID: PMC5490285. 77. Aala F, Badali H, Hashemi Fesharaki S, Boroumand M, Sotoudeh Anvari M, Davari H, Agha Kuchak Afshari S, Khodavaisy S. Coexistence of aspergilloma and pulmonary hydatid cyst in an immunocompetent individual. J Mycol Med. 2017 May 16. pii: 6 S1156-5233(16)30299-2. doi: 10.1016/j.mycmed.2017.04.006. PMID: 28526521. 76. Mohammadi R, Mirhendi H, Hedayati MT, Badali H*. Caspofungin-Non-Susceptible Candida orthopsilosis Isolated from Onychomycosis in Iran. Iran J Public Health. 2017 Feb;46(2):235-241. PubMed PMID: 28451560; PubMed Central PMCID: PMC5402783. 75. Chowdhary A, Hagen F, Sharma C, Al-Hatmi AMS, Giuffrè L, Giosa D, Fan S, Badali H, Felice MR, de Hoog S, Meis JF, Romeo O. Whole Genome-Based Amplified Fragment Length Polymorphism Analysis Reveals Genetic Diversity in Candida africana. Front Microbiol. 2017 Apr 3;8:556. doi: 10.3389/fmicb.2017.00556. eCollection 2017. PubMed PMID: 28421052; PubMed Central PMCID: PMC5377543 74. Risslegger B, Zoran T, Lackner M, Aigner M, Sánchez-Reus F, Rezusta A, Chowdhary A, Taj-Aldeen SJ, Arendrup MC, Oliveri S, Kontoyiannis DP, Alastruey-Izquierdo A, Lagrou K, Lo Cascio G, Meis JF, Buzina W, Farina C, Drogari-Apiranthitou M, Grancini A, Tortorano AM, Willinger B, Hamprecht A, Johnson E, Klingspor L, Arsic-Arsenijevic V, Cornely OA, Meletiadis J, Prammer W, Tullio V, Vehreschild JJ, Trovato L, Lewis RE, Segal E, Rath PM, Hamal P, Rodriguez-Iglesias M, Roilides E, Arikan-Akdagli S, Chakrabarti A, Colombo AL, Fernández MS, Martin-Gomez MT, Badali H, Petrikkos G, Klimko N, Heimann SM, Houbraken J, Uzun O, Edlinger M, Fuente S, Lass-Flörl C. A Prospective International Aspergillus terreus Survey: An EFISG, ISHAM and ECMM Joint Study. Clin Microbiol Infect. 2017 Apr 13. pii: S1198-743X(17)30220-3. doi: 10.1016/j.cmi.2017.04.012. PMID: 28412383. 73. Vaezi A, Fakhim H, Khodavaisy S, Alizadeh A, Nazeri M, Soleimani A, Boekhout T, Badali H. Epidemiological and mycological characteristics of candidemia in Iran: A systematic review and meta-analysis. J Mycol Med. 2017 Mar 16. pii: S1156-5233(17)30007-0. doi: 10.1016/j.mycmed.2017.02.007. Review. PubMed PMID: 28318900. 72. Yazdanparast SA, Mohseni S, De Hoog GS, Aslani N, Sadeh A, Badali H. Consistent high prevalence of Exophiala dermatitidis, a neurotropic opportunist, on railway sleepers. J Mycol Med. 2017 Feb 9. pii: S1156-5233(16)30139-1. doi: 10.1016/j.mycmed.2017.01.007. PubMed PMID: 28190754. 71. Rezai MS, Vaezi A, Fakhim H, Soleimani A, Mohammad Jafari H, Mohseni S, Badali H. Successful treatment with caspofungin of candiduria in a child with Wilms tumor; review of literature. J Mycol Med. 2017 Feb 7. pii: S1156-5233(16)30200-1. doi: 10.1016/j.mycmed.2017.01.006. 70. Mardani M, Aslani N, Geramishoar M, Khodavaisy S, Mohseni S, Badali H*. Disseminated Nocardiosis in an Immunocompetent Individual Infected with Nocardia brasiliensis, an Opportunistic Agent. Arch Clin Infect Dis. 2017 January; 12(1):e37738. 69. Fakhim H, Emami S, Vaezi A, Hashemi SM, Faeli L, Diba K, Dannaoui E, Badali H*. In Vitro Activities of Novel Azole Compounds (ATTAF-1 and ATTAF-2) Against FluconazoleSusceptible and -Resistant Isolates of Candida species. Antimicrob Agents Chemother. 2016 Oct 24. pii: AAC.01106-16. PMID: 27795371. 68. Gohar AA, Badali H, Shokohi T, Nabili M, Amirrajab N, Moazeni M. Expression Patterns of ABC Transporter Genes in Fluconazole-Resistant Candida glabrata. Mycopathologia. 2017 Apr;182 (3-4):273-284. doi: 10.1007/s11046-016-0074-8. PubMed PMID: 27744635. 7 67. Abastabar M, Rahimi N, Meis JF, Aslani N, Khodavaisy S, Nabili M, Rezaei-Matehkolaei A, Makimura K, Badali H*. Potent Activities of Novel Imidazoles (lanoconazole and luliconazole) Against a Collection of Azole Resistant and Susceptible Aspergillus fumigatus strains. Antimicrob Agents Chemother. 2016 Aug 29. pii: AAC.01193-16. PMID: 27572389. 66. Rezazadeh E, Sabokbar A, Moazeni M, Rezai MS, Badali H*. Microdilution in vitro Antifungal Susceptibility Patterns of Candida Species, From Mild Cutaneous to Bloodstream Infections. Jundishapur J Microbiol. 2016 Jul 5;9(7):e34151. doi: 10.5812/jjm.34151. eCollection 2016 Jul. PMID: 27679703. 65. Amirrajab N, Badali H, Didehdar M, Afsarian MH, Mohammadi R, Lotfi N, Shokohi T. In Vitro Activities of Six Antifungal Drugs Against Candida glabrata Isolates: An Emerging Pathogen. Jundishapur J Microbiol. 2016 Apr 23;9(5):e36638. doi: 10.5812/jjm.36638. eCollection 2016 May. PubMed PMID: 27540459; PMCID: PMC4977912. 64. Sharifynia S, Badali H, Sharifi Sorkherizi M, Shidfar MR, Hadian A, Shahrokhi S, Ghandchi G, Rezaie S. In Vitro Antifungal Susceptibility Profiles of Candida albicans Complex Isolated from Patients with Respiratory Infections. Acta Med Iran 2016; 54(6):376-81. PubMed PMID: 27306344. 63. Nabili M, Abdollahi Gohar A, Badali H, Mohammadi R, Moazeni M. Amino acid substitutions in Erg11p of azole-resistant Candida glabrata: Possible effective substitutions and homology modelling. J Glob Antimicrob Resist. 2016 Jun; 5:42-6. PMID: 27436465. 62. Baghi N, Shokohi T, Badali H, Makimura K, Rezaei-Matehkolaei A, Abdollahi M, Didehdar M, Haghani I, Abastabar M. In vitro activity of new azoles luliconazole and lanoconazole compared with ten other antifungal drugs against clinical dermatophyte isolates. Med Mycol. 2016 Oct 1;54(7):757-63. PMID: 27118804 61. Abastabar M, Mirhendi H, Hedayati MT, Shokohi T, Rezaei-Matehkolaei A, Mohammadi R, Badali H, Moazeni M, Haghani I, Ghojoghi A, Akhtari J. Genetic and Morphological Diversity of the Genus Penicillium From Mazandaran and Tehran Provinces, Iran. Jundishapur J Microbiol. 2016 Jan 9;9(1):e28280. doi: 10.5812/jjm.28280. eCollection 2016 Jan. PMID: 27099684 60. Nabili M, Shokohi T, Moazeni M, Khodavaisy S, Aliyali M, Badiee P, Zarrinfar H, Hagen F, Badali H*. High Prevalence of Clinical and Environmental Triazole Resistant Aspergillus fumigatus in Iran: Is It a Challenging Issue?. J Med Microbiol. 2016 Jun;65(6):468-75. PMID: 27008655 59. Khodavaisy S, Badali H, Hashemi SJ, Aala F, Nazeri M, Nouripour-Sisakht S, Sorkherizi MS, Amirizad K, Aslani N, Rezaie S. In vitro activities of five antifungal agents against 199 clinical and environmental isolates of Aspergillus flavus, an opportunistic fungal pathogen. J Mycol Med. 2016 Mar 2. pii: S1156-5233(16)00006-8. doi: 10.1016/j.mycmed.2016.01.002. PMID: 26948143 58. Vaezi A, Moazeni M, Rahimi MT, de Hoog S, Badali H*. Mucormycosis in Iran: a systematic review. Mycoses. 2016 Jul;59(7):402-15. Review. 57. Khodavaisy S, Badali H, Rezaie S, Nabili M, Moghadam KG, Afhami S, Hagen F, Aala F, Hashemi SJ, Meis JF. Genotyping of clinical and environmental Aspergillus flavus isolates from Iran using microsatellites. Mycoses. 2016 Jan 12. doi: 10.1111/myc.12451. PMID: 26756650 8 56. Aliyali M, Badali H, Shokohi T, Moazeni M, Nosrati A, Godazandeh G, Dolatabadi, S, Nabili M. Coinfection of Pulmonary Hydatid Cyst and Aspergilloma: Case Report and Systematic Review. Mycopathologia. 2016 Apr; 181(3-4):255-65. PMID: 26666549 55. Badali H, Fakhim H, Zarei F, Nabili M, Vaezi A, Poorzad N, Dolatabadi S, Mirhendi H. In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex. Mycopathologia. 2016 Apr; 181(3-4):235-40. PMID: 26615417 54. Ansari S, Hedayati MT, Zomorodian K, Pakshir K, Badali H, Rafiei A, Ravandeh M, Seyedmousavi S. Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran. Mycopathologia. 2016 Feb; 181(1-2):89-95. doi: 10.1007/s11046-015-9941-y. PMID: 26369643 53. Afsarian SM, Badali H, Shokohi T, Najafipour S. Molecular Diversity of Candida albicans Isolated from Immunocompromised Patients, Based on MLST Method. Iran J Public Health. 2015 Sep; 44(9):1262-1269. PubMed PMID: 26587501; PMC4645784. 52. Deng S, Tsui CK, Gerrits van den Ende AH, Yang L, Najafzadeh MJ, Badali H, Li R, Hagen F, Meis JF, Sun J, Dolatabadi S, Papierok B, Pan W, de Hoog GS, Liao W. Global Spread of Human Chromoblastomycosis Is Driven by Recombinant Cladophialophora carrionii and Predominantly Clonal Fonsecaea Species. PLoS Negl Trop Dis. 2015 Oct 23;9(10):e0004004. doi: 10.1371/journal.pntd.0004004.eCollection 2015 Oct. PubMed PMID: 26496430; PubMed Central PMCID: PMC4619687. 51. Afshar P, Hedayati MT, Aslani N, Khodavaisy S, Babamahmoodi F, Mahdavi MR, Dolatabadi S, Badali H*. First Autochthonous Coinfected Anthrax in an Immunocompetent Patient. Case Rep Med. 2015;2015:325093. doi:10.1155/2015/325093. Epub 2015 Sep 15. PubMed PMID: 26451148; PubMed Central PMCID: PMC4586956. 50. Mousavi B, Hedayati MT, Teimoori-Toolabi L, Guillot J, Alizadeh A, Badali H*. cyp51A gene silencing using RNA interference in azole-resistant Aspergillus fumigatus. Mycoses. 2015 Dec; 58(12):699-706. doi: 10.1111/myc.12417. PubMed PMID: 26448519. 49. Badali H, Alian S, Fakhim H, Falahatinejad M, Moradi A, Mohammad Davoudi M, Hagen F, Meis JF. Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature. Mycoses. 2015 Dec; 58(12):689-93. doi: 10.1111/myc.12415. PMID: 26444438. 48. Zakeri H, Shokohi T, Badali H, Mayahi S, Didehdar M. Use of Padlock Probes and Rolling Circle Amplification (RCA) for Rapid Identification of Trichophyton Species, Related to Human and Animal Disorder. Jundishapur J Microbiol. 2015 Jul 27;8(7):e19107. doi: 10.5812/jjm.19107v2. eCollection 2015 Jul. PubMed PMID: 26421127 47. Badali H, Khodavaisy S, Fakhim H, de Hoog GS, Meis JF, Chowdhary A. In Vitro Susceptibility Profiles of Eight Antifungal Drugs Against Clinical and Environmental Strains of Phaeoacremonium. Antimicrob Agents Chemother. 2015 Dec; 59(12):7818-22. doi: 10.1128/AAC.01733-15. PMID: 26369976 9 46. Mohammadi R, Abastabar M, Mirhendi H, Badali H, Shadzi S, Chadeganipour M, Pourfathi P, Jalalizand N, Haghani I. Use of Restriction Fragment Length Polymorphism to Rapidly Identify Dermatophyte Species Related to Dermatophytosis. Jundishapur J Microbiol. 2015 Jun 30;8(6):e17296. doi: 10.5812/jjm.8(5)2015.17296. 45. Yazdanparast SA1, Khodavaisy S, Fakhim H, Shokohi T, Haghani I, Nabili M, Gholami H, Ahmadi I, Badali H*. Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis. Mycopathologia; 2015 Dec; 180(5-6):317-23. doi: 10.1007/s11046- 015-9924-z. PMID: 26183965 44. Mohammadi R, Badiee P, Badali H, Abastabar M, Safa AH, Hadipour M, Yazdani H, Heshmat F. Use of restriction fragment length polymorphism to identify Candida species, related to onychomycosis. Adv Biomed Res. 2015 May 11; 4:95. doi: 10.4103/2277-9175.156659. eCollection 2015. PMID: 26015921 43. Badali H, Mohammadi R, Mashedi O, de Hoog GS, Meis JF. In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs. Mycoses. 2015 May; 58(5):303-7. doi: 10.1111/myc.12315. PMID: 25757042. 42. Hashemi SM, Badali H, Irannejad H, Shokrzadeh M, Emami S. Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents. Bioorg Med Chem. 2015 Apr 1; 23(7):1481-91. doi: 10.1016/j.bmc.2015.02.011. PMID: 25740636. 41. Didehdar M, Gokanian A, Sofian M, Mohammadi S, Mohammadi R, Aslani N, Haghani I, Badali H*. First fatal cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran, based on ITS rDNA. J Mycol Med. 2015 Mar;25(1):81-6. doi: 10.1016/j.mycmed.2014.11.003; PMID:25637429 40. Afsarian MH, Badali H, Boekhout T, Shokohi T, Katiraee F. Multilocus sequence typing of Candida albicans isolates from Burn Intensive Care Unit (BICU) in Iran. J Med Microbiol. 2015 Mar;64(Pt 3):248-53. doi: 10.1099/jmm.0.000015. PMID: 25596113 39. Hashemi SM, Badali H, Faramarzi MA, Samadi N, Afsarian MH, Irannejad H, Emami S. Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity. Mol Divers 2015; 19:15–27. PMID: 25182365. 38. Babazadeh-Qazijahani M, Badali H, Irannejad H, Afsarian MH, Emami S. Imidazolylchromanones containing non-benzylic oxime ethers: synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii. Eur J Med Chem 2014; 76: 264 -73. doi: 10.1016/j.ejmech.2014.02.019. PubMed PMID: 24583607. 37. Pei-Ying Feng, G. S. de Hoog, M. J. Najafzadeh, A. H. G. Gerrits van den Ende, J. B. Stielow, H. Badali, W. A. Boeger, V. A. Vicente. Cladophialophora abundans, a novel species of Chaetothyriales isolated from the natural environment. Mycological Progress 2014; DOI 10.1007/s11557-013-0924-4 36. Fesharaki SH, Haghani I, Mousavi B, Kargar ML, Boroumand M, Anvari MS, Abbasi K, Meis JF, Badali H*. Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a 11 drug abuser. J Med Microbiol. 2013 Nov; 62 (Pt 11):1763-7. doi: 10.1099/jmm.0.060954-0. PubMed PMID: 23973985. 35. Badali H, Vaezi A, Haghani I, Yazdanparast SA, Hedayati MT, Mousavi B, Ansari S, Hagen F, Meis JF, Chowdhary A. Environmental study of azole-resistant Aspergillus fumigatus with TR34/L98H mutations in the cyp51A gene in Iran. Mycoses. 2013 Nov; 56(6):659-63. doi: 10.1111/myc.12089. PubMed PMID: 23668594. 34. Badali H, Fernández-González M, Mousavi B, Illnait-Zaragozi MT, González-Rodríguez JC, de Hoog GS, Meis JF. Chromoblastomycosis due to Fonsecaea pedrosoi and F. monophora in Cuba. Mycopathologia. 2013 Jun; 175(5-6):439-44. doi: 10.1007/s11046-013-9634-3. PubMed PMID: 23471535. 33. Bonifaz A, Davoudi MM, de Hoog GS, Padilla-Desgarennes C, Vázquez-González D, Navarrete G, Meis JF, Badali H*. Severe disseminated phaeohyphomycosis in an immunocompetent patient caused by Veronaea botryosa. Mycopathologia. 2013 Jun; 175(5-6):497-503. doi: 10.1007/s11046-013-9632-5. PubMed PMID: 23471534. 32. Hamzehei H, Yazdanparast SA, Davoudi MM, Khodavaisy S, Golehkheyli M, Ansari S, de Hoog GS, Badali H*. Use of rolling circle amplification to rapidly identify species of Cladophialophora potentially causing human infection. Mycopathologia. 2013 Jun; 175(5-6):431-8. doi: 10.1007/s11046-013-9630-7. PubMed PMID: 23471533. 31. Badali H, Yazdanparast SA, Bonifaz A, Mousavi B, de Hoog GS, Klaassen CH, Meis JF. Veronaea botryosa: molecular identification with amplified fragment length polymorphism (AFLP) and in vitro antifungal susceptibility. Mycopathologia. 2013 Jun; 175(5-6):505-13. doi: 10.1007/s11046-013-9631-6. PubMed PMID: 23463524. 30. Pattanaprichakul P, Bunyaratavej S, Leeyaphan C, Sitthinamsuwan P, Sudhadham M, Muanprasart C, Feng P, Badali H, de Hoog GS. An unusual case of Eumycetoma caused by Exophiala jeanselmei after a sea urchin injury. Mycoses. 2013 Jul;56(4):491-4. doi: 10.1111/myc.12050. PubMed PMID: 23406480. 29. Deng S, de Hoog GS, Badali H, Yang L, Najafzadeh MJ, Pan B, Curfs-Breuker I, Meis JF, Liao W. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis. Antimicrob Agents Chemother. 2013 Apr; 57(4):1974-7. doi: 10.1128/AAC.02114-12. PubMed PMID: 23380718; 28. Arzanlou M, Moshari S, Salari M, Badali H*. Molecular characterization and pathogenicity of Phaeoacremonium spp. associated with esca disease of grapevine in Northern Iran. Archives of Phytopathology and Plant Protection 2013; 46(4): 375–388 27. Mirhendi H, Fatemi MJ, Bateni H, Hajabdolbaghi M, Geramishoar M, Ahmadi B, Badali H*. First case of disseminated phaeohyphomycosis in an immunocompetent individual due to Alternaria malorum. Med Mycol. 2013 Feb; 51(2):196-202. doi: 10.3109/13693786.2012.707338. PubMed PMID: 22871097. 26. Agha Kuchak Afshari S, Shokohi T, Aghili R, Badali H. Epidemiology and molecular characterization of Cryptococcus neoformans isolated from pigeon excreta in Mazandaran province, northern Iran. J Mycol Med. 2012 Jun; 22(2):160-6. doi: 0.1016/j.mycmed.2012.02.002. PubMed PMID: 23518018. 11 25. Badali H, Chander J, Bayat M, Seyedmousavi S, Sidhu S, Rani H, Attri A, Handa U, Meis JF, de Hoog GS. Multiple subcutaneous cysts due to Exophiala spinifera in an immunocompetent patient. Med Mycol. 2012 Feb; 50(2):207-13. doi: 10.3109/13693786.2011.603367. PubMed PMID: 21916783. 24. de Hoog GS, Vicente VA, Najafzadeh MJ, Harrak MJ, Badali H, Seyedmousavi S. Waterborne Exophiala species causing disease in cold-blooded animals. Persoonia. 2011 Dec; 27:46-72. doi: 10.3767/003158511X614258. PubMed PMID: 22403476 23. Seyedmousavi S, Badali H, Chlebicki A, Zhao J, Prenafeta-Boldú FX, De Hoog GS. Exophiala sideris, a novel black yeast isolated from environments polluted with toxic alkyl benzenes and arsenic. Fungal Biol. 2011 Oct; 115(10):1030-7. doi: 10.1016/j.funbio.2011.06.004. PubMed PMID: 21944215. 22. Badali H, Prenafeta-Boldu FX, Guarro J, Klaassen CH, Meis JF, de Hoog GS. Cladophialophora psammophila, a novel species of Chaetothyriales with a potential use in the bioremediation of volatile aromatic hydrocarbons. Fungal Biol. 2011 Oct; 115(10):1019-29. doi: 10.1016/j.funbio.2011.04.005. PubMed PMID: 21944214. 21. Sun J, Zhang J, Najafzadeh MJ, Badali H, Li X, Xi L, de Hoog GS. Melanization of a meristematic mutant of Fonsecaea monophora increases tolerance to stress factors while no effects on antifungal susceptibility. Mycopathologia. 2011 Nov; 172(5):373-80. doi: 10.1007/s11046-011- 9439-1. PubMed PMID: 21706309. 20. Badali H, de Hoog GS, Sudhadham M, Meis JF. Microdilution in vitro antifungal susceptibility of Exophiala dermatitidis, a systemic opportunist. Med Mycol. 2011 Nov; 49(8):819-24. doi: 10.3109/13693786.2011.583285. PubMed PMID: 21612562. 19. Badali H, Hedayati MT, Bahoosh M, Kasir A, Ghasemi M, Motahari J, Meis JF, De Hoog GS. Exophiala oligosperma involved in a refractory chronic rhinosinusitis. Eur Rev Med Pharmacol Sci. 2011 Mar; 15(3):319-23. PubMed PMID: 21528779. 18. Badali H, Chander J, Gupta A, Rani H, Punia RS, De Hoog GS, Meis JF. Fatal cerebral phaeohyphomycosis in an immunocompetent individual due to Thielavia subthermophila. J Clin Microbiol. 2011 Jun; 49(6):2336-41. doi: 10.1128/JCM.02648-10. PubMed PMID: 21411574 17. Badali H, Chander J, Gulati N, Attri A, Chopra R, Najafzadeh MJ, Chhabra S, Meis JF, de Hoog GS. Subcutaneous phaeohyphomycotic cyst caused by Pyrenochaeta romeroi. Med Mycol. 2010 Aug; 48(5):763-8. PubMed PMID: 20648971. 16. Badali H, de Hoog GS, Curfs-Breuker I, Klaassen CH, Meis JF. Use of amplified fragment length polymorphism to identify 42 Cladophialophora strains related to cerebral phaeohyphomycosis with in vitro antifungal susceptibility. J Clin Microbiol. 2010 Jul; 48(7):2350-6. doi: 10.1128/JCM.00653-10. PubMed PMID: 20421439 15. Najafzadeh MJ, Badali H, Illnait-Zaragozi MT, De Hoog GS, Meis JF. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrob Agents Chemother. 2010 Apr; 54(4):1636-8. doi: 10.1128/AAC.01655-09. PubMed PMID: 20086140 12 14. Badali H, Bonifaz A, Barrón-Tapia T, Vázquez-González D, Estrada-Aguilar L, Oliveira NM, Sobral Filho JF, Guarro J, Meis JF, De Hoog GS. Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis. Med Mycol. 2010 Aug; 48(5):696-703. doi: 10.3109/13693780903471073. PubMed PMID: 20055741. 13. Badali H, Chander J, Bansal S, Aher A, Borkar SS, Meis JF, De Hoog GS. First autochthonous case of Rhinocladiella mackenziei cerebral abscess outside the Middle East. J Clin Microbiol. 2010 Feb;48(2):646-9. doi: 10.1128/JCM.01855-09. PubMed PMID: 20007402 12. Badali H, de Hoog GS, Curfs-Breuker I, Meis JF. In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection. J Antimicrob Chemother. 2010 Jan; 65(1):175-7. doi: 10.1093/jac/dkp390. PubMed PMID: 19854862. 11. Badali H, Najafzadeh MJ, van Esbroeck M, van den Enden E, Tarazooie B, Meis JF, de Hoog GS. The clinical spectrum of Exophiala jeanselmei, with a case report and in vitro antifungal susceptibility of the species. Med Mycol. 2010 Mar; 48(2):318-27. doi: 10.1080/13693780903148353. PubMed PMID: 19642051. 10. Najafzadeh MJ, Rezusta A, Cameo MI, Zubiri ML, Yus MC, Badali H, Revillo MJ, De Hoog GS. Successful treatment of chromoblastomycosis of 36 years duration caused by Fonsecaea monophora. Med Mycol. 2010 Mar; 48(2):390-3. doi: 10.1080/13693780903008813. PubMed PMID: 19488919. 9. Badali H, De Hoog GS, Curfs-Breuker I, Andersen B, Meis JF. In vitro activities of eight antifungal drugs against 70 clinical and environmental isolates of Alternaria species. J Antimicrob Chemother. 2009 Jun; 63(6):1295-7. doi: 10.1093/jac/dkp109. PubMed PMID: 19336452. 8. Najafzadeh MJ, Gueidan C, Badali H, Van Den Ende AH, Xi L, De Hoog GS. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea. Med Mycol. 2009 Feb; 47(1):17-25. doi: 10.1080/13693780802527178. PubMed PMID: 19107635. 7. Nourian AA, Amiri M, Ataeian A, Haniloo A, Mosavinasab SN, Badali H*. eroepidemiological study for toxocariasis among children in Zanjan-northwest of Iran. Pak J Biol Sci. 2008 Jul 15; 11(14):1844-7. PubMed PMID: 18817228. 6. Badali H, Carvalho VO, Vicente V, Attili-Angelis D, Kwiatkowski IB, Gerrits Van Den Ende AH, De Hoog GS. Cladophialophora saturnica sp. nov., a new opportunistic species of Chaetothyriales revealed using molecular data. Med Mycol. 2009 Feb; 47(1):51-62. doi: 10.1080/13693780802291452. PubMed PMID: 18720218. 5. Badali H, Gueidan C, Najafzadeh MJ, Bonifaz A, van den Ende AH, de Hoog GS. Biodiversity of the genus Cladophialophora. Stud Mycol. 2008; 61:175-91. doi: 10.3114/sim.2008.61.18. PubMed PMID: 19287540 4. Bonifaz A, Badali H, de Hoog GS, Cruz M, Araiza J, Cruz MA, Fierro L, Ponce RM. Tinea nigra by Hortaea werneckii, a report of 22 cases from Mexico. Stud Mycol. 2008; 61:77-82. doi: 10.3114/sim.2008.61.07. PubMed PMID: 19287529 3. de Hoog GS, Nishikaku AS, Fernandez-Zeppenfeldt G, Padín-González C, Burger 13 E, Badali H, Richard-Yegres N, van den Ende AH. Molecular analysis and pathogenicity of the Cladophialophora carrionii complex, with the description of a novel species. Stud Mycol. 2007; 58:219-34. doi: 10.3114/sim.2007.58.08. PubMed PMID: 18491001 2. Nourian AA, Badali H, Khodaverdi M, Hamzehei H, Mohseni M. Airborne Mycoflora of Zanjan-Iran. Int J Agr Biol 2007; 9: 628-630 1.Nourian AA, Badali H, Hamzehei H. Fungal Contamination in Indoor Swimming Pools in Zanjan-Iran 2005, Pak J Biol Sci 2006; 9: 2524-2527. Congress Presentations: 32) Hamid Badali, Jacques F Meis. In vitro susceptibility activities of eight antifungal drugs against clinical and environmental isolates of phaeoacremonium species. 6th Conference of Medical Microbiology (FEMS) June 7-11, 2015, Maastricht, the Netherlands 31) Sadegh Khodavaisy, Hamid Badali, Sasan Rezaie, Farzad Aala. Antifungal susceptibility of aspergillus flavus recovered from clinical and environmental specimens in Iran. 6th Conference of Medical Microbiology (FEMS) June 7-11, 2015, Maastricht, the Netherlands 30) Feng Peiying, Mohammad J. Najafzadeh, Hamid Badali, Sun Jiufeng, Xi Liyan, G. Sybren de Hoog (2015). Identification of common clinical black fungi using RCA technique. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia 29) Mohammad T. Hedayati, Saham Ansari, Kamiar Zomorodian, Keyvan Pakshir, Hamid Badali, Seyedmojtaba Seyedmousavi, Abdollah Rafiei, Mostafa Ravandeh. Antifungal susceptibility testing of clinical dermatophyte isolates from Iran. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia 28) Mohammad H. Afsarian, Hamid Badali, Teun Boekhout, Tahereh Shokohi, Farzad Katiraee. Multilocus sequence typing of Candida albicans isolates from Burn Intensive Care Unit (BICU) in Iran. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia 27) Sadegh Khodavaisy, Parvaneh Afshar, Mohammad Taghi Hedayati, Hamid Badali. First autochthonous co-infection of anthrax and tinea barbae in Iran. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia 26) Sadegh Khodavaisy, Hamid Badali, Peyman Solimani, Samira Salari. Use of PCR-RFLP and PCR-HWP1 for identification of Candida species isolated from cystic fibrosis patients. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia 25) Hamid Badali, Mojtaba Didehdar. First fatal cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Iran, based on ITSrDNA. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia 14 24) Hamid Badali, Melika Laal Kargar, G. Sybren de Hoog. Lack of Exophiala dermatitidis in sputum samples of Cystic fibrosis patients in Iran. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia 23)Somayeh Sharifynia, Hamid Badali, Atefe Hadian, Shadi Shahrokhi, Sadegh Khodavaisy, Fatemeh Noorbakhsh, Ghazale Ghandchi, Sassan Rezaie. Molecular identification and antifungal susceptibility of Candida dubliniensis and Candida africana isolated from clinical specimens. Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia 22) Hamid Badali, Akram Sadeh, Hamed Fakhim, G. Sybren de Hoog, High frequency of Exophiala dermatitidis and E. xenobiotica in railway stations in Iran (2015). Poster presentation at the 19th International Society of Human and Animay Mycology (ISHAM) Congress, 4th - 8th May 2015, Melbourne, Australia 21) Badali H, Mohseni S, Meis J.F, Klaassen C.H.W (2013). Veronaea botryosa: molecular identification with amplified fragment length polymorphism and in vitro antifungal susceptibility (2014). Poster presenter at the 16th Trend in Medical Mycology, 11-14 October, Copenhagen, Denmark 20) Badali H, Mohseni S, Khodavaisy S, de Hoog GS (2013). Use of rolling circle amplification to rapidly identify species of Cladophialophora potentially causing human infection. Poster presenter at the 16th Trend in Medical Mycology, 11-14 October, Copenhagen, Denmark 19) Badali H (2013). Rhinocladiella mackenziei infection: an emerging disease in Middle East. As a speaker at the workshop Black Yeasts and Chromoblastomycosis, 30 November – 1 December, Guangzhou, China. 18) Badali H, Klaassen C.H, Meis J.F, de Hoog G. S (2012). In vitro antifungal susceptibility of eight drugs against Exophiala dermatitidis, a systemic opportunist. Oral presenter at the 18th congress of international society for human and animal mycology 2012, June 10-15, BerlinGermany 17 S. Hashemi, H. Badali, Bromand, Maryam Sotodeh Anvari, Imaan Haghani (2012). Coinfection endocarditis due to Candida albicans and Candida tropicalis in a drug abusers patient. Poster presenter at the 18th congress of international society for human and animal mycology 2012, June 10-15, Berlin-Germany 16) H. Badali, S. Fooladi, J. Chander, S. Mohseni, J. Meis, S.G. de Hoog (2012). Multiple subcutaneous cysts due to Exophiala spinifera in an immunocompetent patient. Poster presenter at the 18th congress of international society for human and animal mycology 2012, June 10-15, Berlin-Germany 15) Badali H, Prenafeta-Boldu F.X, Guarro J, Klaassen C.H, Meis J.F, de Hoog G. S (2011). Cladophialophora psammophila, a novel species of Chaetothyriales with a potential use in the bioremediation of volatile aromatic hydrocarbons. Poster presenter at the 5 th Trends in Medical Mycology, Valencia, Spain, October 2-5, 2011 15 14) Badali H, de Hoog GS, Curfs-Breuker I, Klaassen CH, Meis JF. Use of AFLP analysis for identification of 29 neurotropic Cladophialophora isolates with in vitro activities of eight antifungal drugs. As a poster presenter at the 4th Trends in Medical Mycology, Athens, Greece, October 18-21, 2009 13) Badali H, Najafzadeh MJ, de Hoog GS, Curfs-Breuker I, Meis JF. Microdilution in vitro susceptibility of agents of chromoblastomycosis, Fonsecaea pedrosoi and Fonsecaea monophora, for 8 antifungal agents. As a poster presenter at the 4th Trends in Medical Mycology, Athens, Greece, October 18-21, 2009 12) Badali H, Najafzadeh MJ, Vanesbroeck M, Van den Enden E, Meis JF de Hoog GS. The clinically important black yeast, Exophiala jeanselmei and its in vitro susceptibility to antifungal agents. As a poster presenter at the 4th Trends in Medical Mycology, Athens, Greece, October 18- 21, 2009 11) Badali H, de Hoog GS, Curfs-Breuker I, Meis JF. Antifungal activity of isavuconazole and comparators against chromoblastomycotic Cladophialophora spp. As a poster presenter at the 4th Trends in Medical Mycology, Athens, Greece, October 18-21, 2009 10) Badali H, De Hoog GS, Breuker-Curfs I, Andersen B, Meis JF. In Vitro Activities of Eight Antifungal Drugs against 70 Clinical and Environmental Isolates of Alternaria species. As a speaker at the 17th congress of international society for human and animal mycology 2009, May 25-29 Tokyo-Japan. 9) Badali H, De Hoog GS, Breuker-Curfs I, Heep M, Meis JF In vitro activities of conventional and new antifungal drugs against Rhinocladiella mackenziei an agent of cerebral phaeohyphomycosis. As a speaker at the 17th congress of international society for human and animal mycology 2009, May 25-29 Tokyo-Japan. 8) Najafzadeh MJ, Gueidan C, Badali H, Van Den Ende AHG, De Hoog GS. Genetic diversity and species delimitation in the opportunistic genus Fonsecaea. 17th congress of international society for human and animal mycology 2009, May 25-29 Tokyo-Japan. 7) Badali H, Gueidan C, Gerrits van den ende AHG, De Hoog GS. Cladophialophora with an infectious potential occurring in soft drinks. International congress of mycology, IUMS 2008, August 5- 9 Istanbul-Turkey. 6) Badali H, De Hoog GS, Gerrits van den ende AHG, Najafzadeh MJ, Biodiversity of the genus Cladophialophora, agent of human infection, 3rd trend Medical Mycology congress 2007, October 27- 31 Torino-Italy. 5) Najafzadeh MJ, Badali H, Gerrits van den ende AHG, De Hoog GS. Multilocus Sequence Typing (MLST) of the pathogenic genus Fonsecaea. 3 rd trend Medical Mycology congress 2007, October 27- 31 Torino-Italy. 16 4) Badali H, Vicente V, Attili- Angelis D, Kwiatkowski IB, Gerrits van den ende AHG, De Hoog GS, A new, opportunistic species of Cladophialophora. 12th Netherlands Society for Medical Mycology 2007, December. 3) Badali H, Nourian AA, Mohseni S, Haniloo A, Khodaverdi M, Hamzehei H, Airborne fungi isolated from Zanjan–Iran. 12th International Congress on Infection Disease, 2006, June PortugalLisbon 2) Hedayati MT, Badali H. Mycoflora of stored wheat in warehouses of Mazandaran Province, Iran. 13t VAM congress 2001, August 27-30, Kuala Lumpur-Malaysia. 1) Hedayati MT, Badali H, Vasheghani F, Aghili R, Mohammad pour RA. Immunoblotting analysis of sera from patients with acute and chronic candidal and noncandidal vaginitis for IgE and IgG antibodies to Candida albicans. 13th European congress of clinical microbiology and infectious diseases, 2003 May 10 -13, Glasgow-UK. Results: 15 Scholarships, Awards and Honors: 1- Scholarship for PhD period in field of Medical Mycology of Ministry of Health and Medical Education of Islamic Republic of Iran from 2006 to 2010. 2- ISHAM young investigators travel award worth 1500 $ for an outstanding presentation at the 17th Congress of The International Society for Human and Animal Mycology, Tokyo, Japan, May 2009 3- ECMM young investigators travel award worth 1000 Euro for an outstanding presentation at the 4th Trends in Medical Mycology, Athens, Greece, October 18-21, 2009 4- FEMS young investigators travel award worth 400 Euro for an outstanding presentation at the 6th Conference of Medical Microbiology (FEMS) June 7-11, 2015, Maastricht, the Netherlands 5- Financially supported by an ESCMID observership grant for training at the Department of Medical Microbiology and Infectious Diseases, Canisius- Wilhelmina Hospital, Nijmegen, The Netherland, 2016 and 2017 Teaching Experiences 1) Teaching of Medical mycology course for health and medical students in Zanjan university of Medical Science, School of medicine, from 2003 to 2006. 2) Teaching of Medical mycology course for MSc students of Medical Parasitology in Zanjan university of Medical Science, School of medicine, from 2005 to 2006. 17 3) Teaching of all Medical mycology courses such as fungal genetic, fungal biotechnology and fungal physiology for MSc and PhD students in field of Mycology at Mazandaran university of Medical Science, School of medicine, from 2010 to present. Professional memberships: - Member of the American Society of Microbiology (ASM) - Member of the International Society of Human and Animal Mycology (ISHAM). - Member of the Young International Society of Human and Animal Mycology (ISHAM). - Member of the European Society of Clinical Microbiology and Infection Disease (ESCMID). - The Young ISHAM’ representative for Iran, Turkey and Middle East badali.youngisham@gmail.com - Secretary in Iranian Society of Medical Mycology Ismm1390@gmail.com Specialization and Interest  Epidemiology and clinical courses of severe fungal infections  Antifungal susceptibility testing and to investigate mechanism of actions Severe fungal infections (Aspergillosis and Candidiasis) have emerged worldwide as an important cause of infections among patients undergoing cancer chemotherapy, haematopoetic stem-cell transplantation, or solid organ transplantation. Therefore to determine; distribution, prevalence, epidemiology and strain diversity, describing novel species, to collect azole resistance species, to identify patient population at risk, to determine the clinical pattern of disease, to characterize in vitro susceptibility, to check in vitro susceptibility and drug-drug combinations and to check experimental antifungal drugs in vitro and in vivo in animal models is highly necessary in the hospital, predicting clinical course and applying adequate and cost-effective therapy. 18 REFEREES: 1) Professor G. Sybren de Hoog: CBS-KNAW Fungal Biodiversity Centre, Utrecht, Netherlands and Institute for Biodiversity and Ecosystem Dynamics, University of Amsterdam, Amsterdam, Netherlands, Email address: s.hoog@cbs.knaw.nl 2) Jacques F. Meis: Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital, Nijmegen, Netherlands, Email address: j.meis@cwz.nl